Aktuellt
SENASTE
Bactiguard reported Q1 net sales of SEK 59m (SEB at SEK 52m) with organic net sales growth of 6.3% y/y. The organic sales growth was even better whilst excluding the c. 10% effect of the decision to phase out BIP revenues (were not material in Q1). Wound management is key driver of the beat. Q1 EBITDA was SEK 9m (SEB at SEK 2m). Estimates should come up somewhat following the Q1 print.
LÄS MER
